Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-20T06:35:56.490Z Has data issue: false hasContentIssue false
  • English
  • Français

Catatonia: Harbinger of the Neuroleptic Malignant Syndrome

Published online by Cambridge University Press:  02 January 2018

Denise A. C. White  and
Ashley H. Robins
Denise A. C. White*
Affiliation:
Department of Psychiatry, University of Cape Town and Groote Schuur Hospital
Ashley H. Robins
Affiliation:
Department of Pharmacology, University of Cape Town and Groote Schuur Hospital, Observatory, Cape, South Africa 7925
*
* Department of Psychiatry, University of Cape Town Medical School, Observatory, Cape, South Africa 7925
Get access Rights & Permissions [Opens in a new window]

Abstract

Five consecutive cases of the NMS are presented, in all of which a catatonic state preceded the onset of the condition. Catatonia would appear to represent a highly significant risk factor for the NMS and a possible causal link between the two disorders is suggested.

Type
Brief Reports
Information
The British Journal of Psychiatry , Volume 158 , Issue 3 , March 1991 , pp. 419 - 421
Copyright
Copyright © Royal College of Psychiatrists, 1991 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abrams, R. & Taylor, M. A. (1976) Catatonia: a prospective clinical study. Archives of General Psychiatry, 33, 579–581.CrossRefGoogle ScholarPubMed
Addonizio, G. Susman, V. L. & Roth, S. D. (1986) Symptoms of neuroleptic malignant syndrome in 82 consecutive inpatients. American Journal of Psychiatry, 143, 1587–1590.Google Scholar
Barnes, M. P. Saunders, M. Walls, T. J. et al (1986) The syndrome of Karl Ludwig Kahlbaum. Journal of Neurology, Neurosurgery and Psychiatry, 49, 991–996.Google Scholar
Castillo, E. Rubin, R. T. & Holsboer-Trachsler, E. (1989) Clinical differentiation between lethal catatonia and neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 324–328.Google Scholar
Fricchione, G. L. (1985) Neuroleptic catatonia and its relationship to psychogenic catatonia. Biological Psychiatry, 20, 304–313.Google Scholar
Harsh, H. H. (1987) Neuroleptic malignant syndrome: physiological and laboratory findings in a series of nine cases. Journal of Clinical Psychiatry, 48, 328–333.Google Scholar
Horn, E. Lach, B. Lapierre, Y. et al (1988) Hypothalamic pathology in the neuroleptic malignant syndrome. American Journal of Psychiatry, 145, 617–620.Google Scholar
Itoh, H. Ohtsuka, N. Ogita, K. et al (1977) Malignant neuroleptic syndrome: its present state in Japan and clinical problems. Folia Psychiatrica et Neurologica Japonica, 31, 565–576.Google Scholar
Keck, P. E. Pope, H. G. & McElroy, S. L. (1987) Frequency and presentation of neuroleptic malignant syndrome: a prospective study. American Journal of Psychiatry, 144, 1344–1346.Google Scholar
Keck, P. E. Pope, H. G. Cohen, B. M. et al (1989) Risk factors for neuroleptic malignant syndrome: a case-control study. Archives of General Psychiatry, 46, 914–918.Google Scholar
Mann, S. C. Caroff, S. N. Bleier, H. R. et al (1986) Lethal catatonia. American Journal of Psychiatry, 143, 1374–1381.Google Scholar
Price, D. K. Turnbull, G. J. Gregory, R. P. et al (1989) Neuroleptic malignant syndrome in a case of post-partum psychosis. British Journal of Psychiatry, 155, 849–852.Google Scholar
Rosebush, P. & Stewart, T. (1989) A prospective analysis of 24 episodes of neuroleptic malignant syndrome. American Journal of Psychiatry, 146, 717–725.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.